Endoscope Washer Disinfector Market: as ISO 15883 automated washer-disinfector adoption replaces manual brush-cleaning workflows at hospital central sterile services departments, Joint Commission 2024 real-time HLD cycle tracking mandates create compliance urgency that manual documentation cannot satisfy, so capital investment concentrates in multi-chamber systems with integrated RFID scope tracking, and the SteelcoBelimed JV together with the HOYA-Wassenburg acquisition are reshaping competition in Europe and Asia Pacific toward integrated endoscope-plus-reprocessor vendor bundles.

The global endoscope washer disinfector market size was USD 517.60 Million in 2025 and is expected to register a revenue CAGR of 6.8% during the forecast period. Market revenue growth is driven by factors such as progressive ISO 15883 automated washer-disinfector adoption replacing manual brush-cleaning workflows, RFID-enabled digital compliance integration satisfying Joint Commission 2024 real-time HLD tracking mandates, and as well as competitive landscape consolidation through the SteelcoBelimed JV and HOYA-Wassenburg acquisition creating integrated endoscope-plus-reprocessor vendor offerings. The first driving factor is ISO 15883 compliance requirements compelling hospital central sterile services departments and ambulatory endoscopy suites to replace manual cleaning workflows with automated washer-disinfector systems that can validate cleaning efficacy through A0 value measurement, document each disinfection cycle through integrated data logging, and eliminate the occupational aldehyde vapour exposure that manual glutaraldehyde-based HLD workflows impose on sterile processing department staff, with multiple European occupational health authorities recommending replacement of manual aldehyde HLD with peracetic acid or thermal disinfection automated systems. The second driving factor is Joint Commission 2024 revised HLD cycle tracking mandates requiring real-time documentation of every disinfection cycle, compelling US hospitals without current digital logging capability to invest in automated washer-disinfector systems with integrated electronic compliance records and scope-level RFID traceability, with Olympus Hytrack integration associating each endoscope serial number with its specific reprocessing cycle data and STERIS expanding its compliance chain through its December 2024 Integrated Medical Systems acquisition adding drying cabinets and storage to a seamless chain-of-custody suite. The third driving factor is the HOYA 100% acquisition of Wassenburg Medical in November 2023 and the SteelcoBelimed joint venture finalised in June 2024, both creating integrated endoscope-plus-reprocessor commercial offerings that allow hospital procurement committees to obtain scope-reprocessor compatibility validation and unified service responsibility from a single vendor rather than managing separate endoscope and AER procurement tracks independently. These are some of the key factors driving revenue growth of the market.

A second layer of demand comes from the way validated scope-reprocessor compatibility assurance accumulates commercial value over time as infection control documentation requirements become more stringent, which allows manufacturers offering integrated scope-plus-AER combinations to command premium pricing above standalone AER competitors. Once a hospital procurement committee selects a washer-disinfector validated for a specific endoscope manufacturer's scope population, the switching cost of replacing the AER includes revalidation of cleaning efficacy, retraining of sterile processing staff, and renegotiation of service contracts that cover both the scope inventory and the reprocessing system, creating a multi-year commercial lock-in that sustains recurring consumable revenue for the AER manufacturer. As a result, demand and revenue share are concentrating around manufacturers that can offer both the flexible endoscope and the validated reprocessing system, and the forecast tilts toward these integrated vendors rather than standalone AER specialists competing on equipment specification alone. For instance, in September 2024, the FDA cleared Custom Ultrasonics' Ivyland manufacturing facility for the System 83 Plus washer-disinfector, one of several regulatory and commercial events that reshaped the competitive landscape in the 12 months to Q2 2026. These are some of the key factors driving revenue growth of the market.

The clearest driver of demand is the progressive replacement of manual brush-cleaning flexible endoscope reprocessing workflows with ISO 15883-validated automated washer-disinfector systems at hospital central sterile services departments and ambulatory endoscopy suites, driven by both regulatory compliance requirements and staff occupational health mandates. Automated washer-disinfectors work commercially because they simultaneously satisfy the A0 value validation requirement for thermal disinfection efficacy, the protein residual testing requirement for cleaning efficacy, and the cycle data logging requirement for regulatory audit trail documentation in a single integrated cycle that replaces 40 to 100 manual cleaning steps requiring operator chemical exposure. Manual brush-cleaning of flexible endoscopes requires sterile processing staff to handle high-level disinfectants including glutaraldehyde or ortho-phthalaldehyde and perform detailed channel flushing and elevator mechanism brushing steps, with documented occupational exposure risks from aldehyde vapour inhalation leading multiple European occupational health authorities to recommend replacement of manual aldehyde-based HLD with automated washer-disinfector systems using peracetic acid or thermal disinfection cycles. In June 2023, Olympus launched the ETD Endoscope Washer Disinfector in Basic and Premium versions with a glutaraldehyde-free peracetic acid chemistry system and optimised water consumption, and Getinge introduced the GEW 888 neo in April 2024 extending the hospital CSSD washer-disinfector expertise into biopharmaceutical manufacturing cleanroom environments. Belimed posted 7.3% organic hospital-segment growth in Q3 2024 per commercial reporting, and NHS England's GBP 4.1 billion endoscopy infrastructure programme is driving AER procurement at NHS trust endoscopy units expanding colonoscopy and upper GI endoscopy capacity. These are some of the key factors driving revenue growth of the market.

The second driver is the accelerating integration of RFID scope identification with automated washer-disinfector cycle data logging to create scope-level electronic compliance records that satisfy Joint Commission 2024 revised HLD cycle tracking mandates and FDA duodenoscope surveillance recommendations. RFID compliance integration works commercially because the Joint Commission 2024 mandate requiring real-time documentation of every HLD cycle creates immediate institutional demand for washer-disinfector systems with integrated RFID scope identification and digital cycle data output to electronic health record or sterile processing management system platforms, converting the compliance mandate into a capital equipment procurement decision at facilities without current digital documentation capability. Olympus Hytrack uses RFID tags embedded in Olympus flexible endoscopes to automatically record each specific endoscope serial number loaded into the ETD washer-disinfector basket, associating scope identity with complete cycle data for FDA duodenoscope post-market surveillance and Joint Commission infection control compliance. STERIS expanded its electronic compliance capability through its December 2024 Integrated Medical Systems acquisition, adding drying cabinets and storage to a seamless chain-of-custody suite that provides electronic compliance records across all post-procedure endoscope handling steps from cleaning through storage to next patient use. The effect on the market is that RFID integration converts washer-disinfector procurement from a capital equipment decision into a compliance infrastructure decision, which accelerates replacement cycle timelines at facilities receiving Joint Commission citations or FDA warning letters related to inadequate endoscope reprocessing documentation. These are some of the key factors driving revenue growth of the market.

The SteelcoBelimed joint venture combining Steelco's Italian washer-disinfector manufacturing scale with Belimed's Swiss CSSD sterilization engineering creates a European-headquartered CSSD platform with product breadth across automated endoscope reprocessors, instrument washers, and steam sterilizers capable of outfitting complete hospital sterile processing departments from a single qualified vendor. This completeness of portfolio directly addresses European public hospital tender frameworks that require multi-category CSSD equipment from a single qualified supplier.

The third driver is the wave of consolidation transactions restructuring the endoscope washer-disinfector market toward integrated endoscope-plus-AER vendor combinations that mirror the Olympus ETD-plus-Hytrack commercial model that has been commercially effective for Olympus at US and European hospital endoscopy department accounts. Consolidation works commercially because the hospital procurement committee that selects a scope-reprocessor bundle from a single manufacturer obtains validated compatibility assurance, unified service responsibility across both the scope inventory and the reprocessing system, and the ability to hold a single vendor accountable for any reprocessing-related infection control failure, reducing the procurement risk compared to managing separate scope and AER vendor relationships. HOYA completed the 100% acquisition of Wassenburg Medical in November 2023, becoming the sole shareholder of the Netherlands-based manufacturer of the WD 250 and WD 440 multi-channel washer-disinfectors, enabling full integration with HOYA Pentax Medical's flexible endoscope commercial infrastructure across European and Asia Pacific hospital markets. Metall Zug and Miele finalised the SteelcoBelimed joint venture in June 2024 under CEO Dr Christian Kluge, combining Steelco's Italian washer-disinfector manufacturing platform and Belimed's Swiss sterilization engineering expertise to compete with STERIS's comprehensive CSSD portfolio in European public hospital tenders. The effect on the market is that three separate integrated platforms, Olympus-ETD, HOYA-Wassenburg, and SteelcoBelimed, now compete for European hospital endoscopy department procurement decisions that historically defaulted to STERIS or standalone AER specialist vendors, increasing competitive intensity and expanding the addressable market for premium multi-chamber AER procurement decisions at European hospital accounts. These are some of the key factors driving revenue growth of the market.

However, the endoscope washer disinfector market faces adoption constraints from high capital costs and growing single-use endoscope conversion. Because multi-chamber automated washer-disinfector installations range from USD 50,000 to USD 200,000 per unit, community hospitals and outpatient GI centres with limited endoscope inventory sizes that cannot justify AER capital expenditure against current procedure volumes remain reliant on manual or semi-automated cleaning workflows that cannot satisfy Joint Commission 2024 digital documentation requirements, creating a two-tier compliance market where resourced facilities upgrade and constrained facilities face growing regulatory exposure. Growing conversion to single-use disposable endoscopes in bronchoscopy and ureteroscopy applications eliminates the installed endoscope inventory at departments fully converting to single-use formats, removing the procedural volume that justifies AER capital investment in those clinical departments and creating a long-term headwind for washer-disinfector market volume growth in those specific applications even as core GI endoscopy volumes continue to grow. Extended equipment replacement cycles of 8 to 15 years for washer-disinfector capital equipment at facilities that installed current systems within the last decade limit the near-term addressable replacement market for new RFID-connected AER models, as facilities with compliant existing systems have limited incentive to replace functional equipment before the replacement cycle milestone even when new models offer superior digital compliance features. These factors substantially limit endoscope washer disinfector market growth over the forecast period.

Based on type, the global endoscope washer disinfector market is segmented into single chamber washer disinfectors and multi-chamber washer disinfectors. Multi-chamber systems hold the largest revenue share at approximately 54% of 2025 market revenue, providing simultaneous parallel processing of multiple endoscopes through separate pre-wash, wash, rinse, and disinfection chambers that eliminate cross-contamination risk between cleaning and disinfection stages while minimising total reprocessing cycle time per scope at high-volume hospital endoscopy suites processing 20 to 50 flexible endoscopes per day. Single chamber washer disinfectors are expected to register a rapid revenue growth rate in the global endoscope washer disinfector market over the forecast period, driven by ambulatory surgical centre and outpatient GI centre adoption of lower-capital-cost single-chamber systems that satisfy ISO 15883 validation requirements at procedure volumes not requiring multi-channel throughput capacity, which is why Custom Ultrasonics System 83 Plus and STERIS single-chamber AER systems are the primary procurement choices at outpatient endoscopy settings.

Based on end-use, the global endoscope washer disinfector market is segmented into hospitals including CSSD and endoscopy suites, ambulatory surgical centres, and specialty clinics and outpatient GI centres. Hospitals hold the largest revenue share, driven by the high daily flexible endoscope reprocessing volumes at hospital gastroenterology, pulmonology, and urology endoscopy departments that require multi-chamber high-throughput automated washer-disinfectors capable of processing the full scope inventory across multiple reprocessing cycles per day while maintaining compliance documentation for each scope and cycle. Ambulatory surgical centres are expected to register the most rapid revenue growth rate in the global endoscope washer disinfector market over the forecast period, driven by the migration of colonoscopy and upper GI endoscopy procedures from hospital outpatient departments to dedicated ASC settings at facilities requiring AER installation as a prerequisite to endoscopy programme commissioning.

Based on regional analysis, the endoscope washer disinfector market in North America accounted for largest revenue share in 2025. The United States drives the regional position through Joint Commission 2024 real-time HLD cycle tracking standards creating compliance urgency for hospitals without digital documentation capability, FDA endoscope reprocessing guidance for duodenoscopes mandating validated AER systems with RFID traceability, and STERIS's dominant commercial position in AER systems and endoscope cleaning chemistry services at US hospital accounts. The September 2024 FDA clearance of Custom Ultrasonics' Ivyland manufacturing facility for the System 83 Plus washer-disinfector restored a non-STERIS AER procurement option for US hospitals evaluating competitive alternatives for colonoscope and gastroscope reprocessing departments, contributing meaningful competitive signal to the AER procurement landscape even if volume share shift depends on Custom Ultrasonics rebuilding its commercial infrastructure following the manufacturing resumption.

The market in Europe is expected to register the fastest revenue growth rate over the forecast period. Germany, the United Kingdom, France, and Scandinavia represent the four largest national endoscope washer-disinfector markets in Europe. The SteelcoBelimed joint venture finalised in June 2024 creates a European-headquartered platform capable of outfitting complete hospital CSSD departments from a single vendor and competing with STERIS's comprehensive portfolio in European public hospital tender markets. The NHS GBP 4.1 billion endoscopy infrastructure programme is driving washer-disinfector procurement at NHS trust endoscopy units commissioning new or expanded capacity, and HOYA Corporation's 100% Wassenburg Medical acquisition establishes the HOYA-Pentax Medical integrated European flexible endoscope and AER commercial offering. The 2026 to 2027 supply environment for European AER manufacturers is not materially affected by Iran-US sanctions, as washer-disinfector capital equipment does not rely on Strait of Hormuz logistics corridors for primary component supply chains, though peracetic acid chemistry precursor costs carry some elevated input cost from regional chemical supply disruption.

The market in Asia Pacific is expected to register a rapid revenue growth rate over the forecast period. Japan, China, South Korea, and Australia represent the four largest national endoscope washer-disinfector markets in the region. Japan Gastrointestinal Endoscopy Society guidelines published in 2022 specify automated washer-disinfector use as the preferred flexible endoscope reprocessing method at Japanese hospital and endoscopy clinic settings, creating a regulatory compliance driver for AER adoption across Japan's estimated 14,800 gastrointestinal endoscopy facilities. China's National Health Commission 2024 infection control directives mandating standardised endoscope reprocessing at licensed endoscopy centres create demand for automated washer-disinfector systems at mid-tier provincial hospital endoscopy departments where manual cleaning had been the predominant reprocessing approach.

The market in Latin America is expected to register a moderate revenue growth rate over the forecast period. Brazil and Mexico represent the two largest national endoscope washer-disinfector markets. Brazil's ANVISA ISO 15883 harmonisation in 2024 creates compliance pressure for Brazilian hospital CSSDs to upgrade from manual cleaning to validated automated washer-disinfector systems, and the indirect effects of Iran-US sanctions on South American freight routes have maintained elevated import costs for washer-disinfector components entering Brazilian and Mexican distribution networks through 2026.

The market in Middle East and Africa is expected to register a moderate revenue growth rate over the forecast period. Saudi Arabia and the UAE represent the primary GCC markets. Saudi Vision 2030 healthcare mega-project funding is driving endoscopy suite build-out at national hospitals including the 1,000-bed National Hospital and Medical City projects, each requiring washer-disinfector procurement for new endoscopy departments as a prerequisite to commissioning.